AG-86893

· Allgenesis Biotherapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AG-86893, covering 2020-11-06 to 2020-11-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Response to AG-86893 in Patients With Pterygium Hyperemia [Phase 2]